A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography

Biomed Chromatogr. 2003 Dec;17(8):500-3. doi: 10.1002/bmc.258.

Abstract

A simple high-performance liquid chromatographic method was developed for the simultaneous determination of the therapeutic levels of acyclovir and ganciclovir in human plasma. After precipitation of plasma proteins with 6% perchloric acid, acyclovir and ganciclovir were simultaneously determined by reversed-phase chromatography with spectophotometric detection at 254 nm. The peak heights for acyclovir and ganciclovir were linearly related to their concentrations ranging from 0.063 to 2.080 micro g/mL. The recovery was 100.48-102.84% for acyclovir and 99.26-103.07% for ganciclovir. The intra- and inter-day relative standard deviation values were in the range 0.186-8.703% for acyclovir and 0.137-6.424% for ganciclovir. The detection limits for both compounds were 0.01 micro g/mL determined as the signal-to-noise ratio of 3. The present method is applicable to therapeutic monitoring during antiviral medication.

MeSH terms

  • Acyclovir / blood*
  • Antiviral Agents / blood*
  • Chromatography, High Pressure Liquid / methods*
  • Ganciclovir / blood*
  • Humans
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antiviral Agents
  • Ganciclovir
  • Acyclovir